Skip to content

Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling)

An Investigator-initiated Study Assessing the Effect of Intermittent Pneumatic Compression (IPC) on Symptoms and Quality of Life in Women With Lipo-lymphedema (Lipedema With Swelling)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04213989
Enrollment
36
Registered
2019-12-30
Start date
2020-01-31
Completion date
2021-11-24
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipedema, Lipolymphedema

Brief summary

Lipedema is a connective tissue disorder that affects up to 10% of women. It is characterized by painful, swollen subcutaneous tissue and disproportionate fat accumulation (primarily in the lower limbs, however it can spread to the abdomen and arms). Patients are often not aware they are affected by this disease; rather, they think they are just overweight or obese. Patients with lipedema often feel frustrated and uncomfortable as symptoms such as heaviness, pain, and easy bruising impact quality of life. Affected limbs can become so large and heavy that daily tasks such as walking, cleaning, or shopping become impossible. There is currently no cure for lipedema, thus treatment focuses on symptom management and improved patient-reported outcomes. At present, the two main courses of treatment include non-surgical conservative treatment (e.g., Comprehensive Decongestive Therapy (CDT), diet, exercise, emotional/psychological/social support) and lymph-sparing liposuction performed by a surgeon trained in lipedema treatment. The primary goals for treatment include: reduction/elimination of inflammation, swelling, and pain; increase in lymphatic flow, which reduces/eliminates excessive fluid and swelling; overall management of the physical impact of lipedema; and quality of life improvements which can include emotional, psychological/mental, spiritual, and social enhancement in addition to physical management. Intermittent Pneumatic Compression (IPC) devices are often used as home-therapy to treat secondary lymphedema or lipo-lymphedema (lipedema with swelling) and may be helpful in preventing the progression of lipedema. IPC use moves lymphatic fluid and supports the elimination of proteinaceous fluids, thus leading to improved patient-reported symptoms, decreased limb girth and volume, increased elasticity of tissues, and fewer episodes of infection. The purpose of this study is to assess whether 3-4 weeks of IPC usage is associated with alleviation of symptoms and improvement in quality of life in women with lipo-lymphedema (lipedema with swelling).

Interventions

DEVICEFlexitouch Plus and Conservative Care

A segmental, programmable, gradient advanced pneumatic compression device. The system consists of a controller unit and garments, and provides in-home manual lymphatic drainage therapy in the legs for approximately 1 hour daily. Conservative care may include 30-40 mmHg graduated compression up to waist, dietary counseling, exercise, and/or referral for CDT.

May include 30-40 mmHg graduated compression up to waist, dietary counseling, exercise, and/or referral for CDT.

Sponsors

Tactile Medical
CollaboratorINDUSTRY
Thomas Wright, MD
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Eligible patients will be randomized to conservative care or Flexitouch Plus and conservative care at Screening. Subjects have up to 60 days to acquire treatment through commercial means and commence treatment. Follow-up will take place 3-4 weeks after treatment commences.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Female age 18-70 years * Stage 2-3 (Schmeller Type 2-3) lipedema with secondary lymphedema * Willing and able to follow prescribed care for study period * Able to access (via self-pay, patient assistance, or insurance programs) prescribed care within 60 days of Screening visit

Exclusion criteria

* BMI \> 50 * Heart failure (acute pulmonary edema, decompensated acute heart failure) * Pacemaker or implantable cardioverter defibrillator (ICD) * Acute venous disease (acute thrombophlebitis, acute deep venous thrombosis, acute pulmonary embolism) * Severe peripheral artery disease (critical limb ischemia including ischemic rest pain, arterial wounds, or gangrene) * Active skin or limb infection/inflammatory disease (acute cellulitis, other uncontrolled skin or untreated inflammatory skin disease) on the arms or trunk * Active cancer (cancer that is currently under treatment, but not yet in remission) * Poorly controlled kidney disease (glomerular filtration rate \< 30 mls per minute), hypoproteinemia, pulmonary hypertension, hypothyroidism, cyclic edema, or Munchausen Syndrome * Any circumstance where increased lymphatic or venous return is undesirable * Currently pregnant or trying to become pregnant

Design outcomes

Primary

MeasureTime frameDescription
Patient-Reported Quality of LifeChanges between Screening and 3-4 weeks will be assessedRAND 36-Item Short Form Survey Instrument (SF-36) 1.0 is a global assessment of health impacts on quality of life that taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. All items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively.
Patient-Reported PainChanges between Screening and 3-4 weeks will be assessedWong Baker Faces Scale is a self-assessment tool that is easily understood by patients, so they are able to choose the face that best illustrates the physical pain they are experiencing associated with their lipo-lymphedema. Face 0 doesn't hurt at all. Face 2 hurts just a little bit. Face 4 hurts a little bit more. Face 6 hurts even more. Face 8 hurts a whole lot. Face 10 hurts as much as you can imagine, although you don't have to be crying to have this worst pain.
Patient-Reported Symptoms of Lipo-LymphedemaChanges between Screening and 3-4 weeks will be assessedNRS Symptom Survey is a 6-item survey that asks patients to rate their perceptions of swelling, heaviness, pain, fatigue, tenderness, and tightness independently for each leg using a 10-point numerical rating scale where 0 represents none/not present and 10 is worst imaginable. All items are scored so that a low score is associated with fewer symptoms (defines a more favorable health state). The lowest and highest possible scores per leg are 0 and 60, respectively, with a combined total score between 0 and 120.
Change in Circumferential Measurements Over TimeChanges between Screening and 3-4 weeks will be assessedTape measurements along both legs
Patient-Reported Pain InterferenceChanges between Screening and 3-4 weeks will be assessedPROMIS Item Bank v1.0 - Pain Interference - Short Form 6b is a 6 item survey that measures self-reported consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. All items are scored so that a low score is associated with less pain interference (a more favorable health state). In addition, each item is scored on a 1 to 5 range so that the lowest and highest possible scores are 6 and 30, respectively.

Secondary

MeasureTime frameDescription
Change in Bioimpedance Measurements Over TimeChanges between Screening and 3-4 weeks will be assessedInBody 770 whole body and segmental extracorporeal body weight / total body weight ratios
Patient-Reported MobilityChanges between Screening and 3-4 weeks will be assessedPROMIS Item Bank v2.0 - Mobility is a 15-item survey that focuses on activities of physical mobility such as getting out of bed or a chair to activities such as running. All items are scored so that a high score is associated with more mobility (a more favorable health state). In addition, each item is scored on a 5 to 1 range so that the highest and lowest possible scores are 75 and 15, respectively.

Countries

United States

Participant flow

Participants by arm

ArmCount
Conservative Care
Conservative care (may include 30-40 mmHg graduated compression up to waist, dietary counseling, exercise, and/or referral for CDT) Conservative Care: May include 30-40 mmHg graduated compression up to waist, dietary counseling, exercise, and/or referral for CDT.
14
Flexitouch Plus and Conservative Care
Flexitouch Plus with conservative care Flexitouch Plus and Conservative Care: A segmental, programmable, gradient advanced pneumatic compression device. The system consists of a controller unit and garments, and provides in-home manual lymphatic drainage therapy in the legs for approximately 1 hour daily. Conservative care may include 30-40 mmHg graduated compression up to waist, dietary counseling, exercise, and/or referral for CDT.
12
Total26

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up04
Overall StudyPhysician Decision10
Overall StudyWithdrawal by Subject32

Baseline characteristics

CharacteristicConservative CareFlexitouch Plus and Conservative CareTotal
Age, Continuous42.1 years
STANDARD_DEVIATION 9.6
44.6 years
STANDARD_DEVIATION 9.5
43.3 years
STANDARD_DEVIATION 9.4
BMI37.0 kg/m^2
STANDARD_DEVIATION 7.5
35.9 kg/m^2
STANDARD_DEVIATION 5.2
36.5 kg/m^2
STANDARD_DEVIATION 6.4
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14 Participants12 Participants26 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
12 Participants12 Participants24 Participants
Region of Enrollment
United States
14 participants12 participants26 participants
Sex: Female, Male
Female
14 Participants12 Participants26 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 12
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 140 / 12

Outcome results

Primary

Change in Circumferential Measurements Over Time

Tape measurements along both legs

Time frame: Changes between Screening and 3-4 weeks will be assessed

ArmMeasureGroupValue (MEAN)
Conservative CareChange in Circumferential Measurements Over TimeAnkle-0.5 cm
Conservative CareChange in Circumferential Measurements Over TimeCalf-1.3 cm
Conservative CareChange in Circumferential Measurements Over TimeKnee-2.4 cm
Conservative CareChange in Circumferential Measurements Over TimeThigh-1.7 cm
Conservative CareChange in Circumferential Measurements Over TimeHip-0.4 cm
Conservative CareChange in Circumferential Measurements Over TimeWaist-2.4 cm
Flexitouch Plus and Conservative CareChange in Circumferential Measurements Over TimeHip3.2 cm
Flexitouch Plus and Conservative CareChange in Circumferential Measurements Over TimeAnkle-1.0 cm
Flexitouch Plus and Conservative CareChange in Circumferential Measurements Over TimeThigh-3.0 cm
Flexitouch Plus and Conservative CareChange in Circumferential Measurements Over TimeCalf-2.0 cm
Flexitouch Plus and Conservative CareChange in Circumferential Measurements Over TimeWaist-2.3 cm
Flexitouch Plus and Conservative CareChange in Circumferential Measurements Over TimeKnee-4.7 cm
Primary

Patient-Reported Pain

Wong Baker Faces Scale is a self-assessment tool that is easily understood by patients, so they are able to choose the face that best illustrates the physical pain they are experiencing associated with their lipo-lymphedema. Face 0 doesn't hurt at all. Face 2 hurts just a little bit. Face 4 hurts a little bit more. Face 6 hurts even more. Face 8 hurts a whole lot. Face 10 hurts as much as you can imagine, although you don't have to be crying to have this worst pain.

Time frame: Changes between Screening and 3-4 weeks will be assessed

ArmMeasureValue (MEAN)
Conservative CarePatient-Reported Pain-0.8 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Pain-0.8 score on a scale
Primary

Patient-Reported Pain Interference

PROMIS Item Bank v1.0 - Pain Interference - Short Form 6b is a 6 item survey that measures self-reported consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. All items are scored so that a low score is associated with less pain interference (a more favorable health state). In addition, each item is scored on a 1 to 5 range so that the lowest and highest possible scores are 6 and 30, respectively.

Time frame: Changes between Screening and 3-4 weeks will be assessed

ArmMeasureValue (MEAN)
Conservative CarePatient-Reported Pain Interference-1.4 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Pain Interference-3.0 score on a scale
Primary

Patient-Reported Quality of Life

RAND 36-Item Short Form Survey Instrument (SF-36) 1.0 is a global assessment of health impacts on quality of life that taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. All items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively.

Time frame: Changes between Screening and 3-4 weeks will be assessed

ArmMeasureGroupValue (MEAN)
Conservative CarePatient-Reported Quality of LifeGeneral health-2.7 score on a scale
Conservative CarePatient-Reported Quality of LifePhysical functioning2.6 score on a scale
Conservative CarePatient-Reported Quality of LifeRole limitations due to physical functioning-1.2 score on a scale
Conservative CarePatient-Reported Quality of LifeEmotional wellbeing2.8 score on a scale
Conservative CarePatient-Reported Quality of LifeRole limitations due to emotional problems-10.9 score on a scale
Conservative CarePatient-Reported Quality of LifeEnergy/fatigue4.8 score on a scale
Conservative CarePatient-Reported Quality of LifeSocial functioning9.9 score on a scale
Conservative CarePatient-Reported Quality of LifePain4.5 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifePain10.2 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifeGeneral health1.3 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifeRole limitations due to emotional problems-2.2 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifePhysical functioning5.3 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifeSocial functioning-2.2 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifeRole limitations due to physical functioning1.4 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifeEnergy/fatigue0.7 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Quality of LifeEmotional wellbeing-1.0 score on a scale
Primary

Patient-Reported Symptoms of Lipo-Lymphedema

NRS Symptom Survey is a 6-item survey that asks patients to rate their perceptions of swelling, heaviness, pain, fatigue, tenderness, and tightness independently for each leg using a 10-point numerical rating scale where 0 represents none/not present and 10 is worst imaginable. All items are scored so that a low score is associated with fewer symptoms (defines a more favorable health state). The lowest and highest possible scores per leg are 0 and 60, respectively, with a combined total score between 0 and 120.

Time frame: Changes between Screening and 3-4 weeks will be assessed

ArmMeasureGroupValue (MEAN)
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaFatigue-Left Leg-1.4 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTenderness-Left Leg-0.6 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaPain-Left Leg-0.3 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTightness-Right Leg-0.9 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTightness-Left Leg-1.2 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaSwelling-Left Leg-0.5 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaHeaviness-Left Leg-0.9 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaSwelling-Right Leg-0.7 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaPain-Right Leg-0.1 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaHeaviness-Right Leg-0.8 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaFatigue-Right Leg-1.8 score on a scale
Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTenderness-Right Leg-0.1 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaHeaviness-Right Leg-0.5 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaHeaviness-Left Leg-1.0 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaPain-Left Leg-1.4 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTenderness-Left Leg-0.2 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTightness-Left Leg-1.8 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaSwelling-Left Leg-0.2 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaFatigue-Right Leg-0.3 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTenderness-Right Leg0.1 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaTightness-Right Leg-1.6 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaFatigue-Left Leg-0.6 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaSwelling-Right Leg0.1 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Symptoms of Lipo-LymphedemaPain-Right Leg-0.5 score on a scale
Secondary

Change in Bioimpedance Measurements Over Time

InBody 770 whole body and segmental extracorporeal body weight / total body weight ratios

Time frame: Changes between Screening and 3-4 weeks will be assessed

Population: Each participant underwent circumferential measurement at baseline and at follow-up. Patients were measured at 4 sites on each leg (narrowest part of the ankle, largest part of the calf, top of knee cap, and thickest part of the upper thigh), the widest part of the hips and the widest part of the waist.

ArmMeasureGroupValue (MEAN)
Conservative CareChange in Bioimpedance Measurements Over TimeWhole body-0.001 ohms
Conservative CareChange in Bioimpedance Measurements Over TimeTrunk-0.001 ohms
Conservative CareChange in Bioimpedance Measurements Over TimeArms0.000 ohms
Conservative CareChange in Bioimpedance Measurements Over TimeLegs-0.003 ohms
Flexitouch Plus and Conservative CareChange in Bioimpedance Measurements Over TimeLegs-0.004 ohms
Flexitouch Plus and Conservative CareChange in Bioimpedance Measurements Over TimeWhole body-0.002 ohms
Flexitouch Plus and Conservative CareChange in Bioimpedance Measurements Over TimeArms0.000 ohms
Flexitouch Plus and Conservative CareChange in Bioimpedance Measurements Over TimeTrunk-0.002 ohms
Secondary

Patient-Reported Mobility

PROMIS Item Bank v2.0 - Mobility is a 15-item survey that focuses on activities of physical mobility such as getting out of bed or a chair to activities such as running. All items are scored so that a high score is associated with more mobility (a more favorable health state). In addition, each item is scored on a 5 to 1 range so that the highest and lowest possible scores are 75 and 15, respectively.

Time frame: Changes between Screening and 3-4 weeks will be assessed

ArmMeasureValue (MEAN)
Conservative CarePatient-Reported Mobility2.9 score on a scale
Flexitouch Plus and Conservative CarePatient-Reported Mobility-0.6 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026